The role of mitomycin C in the treatment of patients with advanced colorectal cancer resistant to 5-fluorouracil-folinic acid chemotherapy

被引：5

作者：

Grumett, SA ^{[1
]}

Archer, VR ^{[1
]}

Midgley, R ^{[1
]}

Mulholland, P ^{[1
]}

Nicum, S ^{[1
]}

Blewitt, L ^{[1
]}

Kerr, DJ ^{[1
]}

机构：

[1] Univ Birmingham, CRC, Inst Canc Studies, Birmingham B15 2TT, W Midlands, England

来源：

ANNALS OF ONCOLOGY | 2001年 / 12卷 / 04期

关键词：

D O I：

10.1023/A:1011106917263

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：575 / 575

页数：1

共 11 条

[1] A dose-escalation phase II clinical trial of infusional mitomycin C for 7 days in patients with advanced measurable colorectal cancer refractory or resistant to 5-fluorouracil [J].

Anderson, N ;

Lokich, J ;

Moore, C ;

Bern, M ;

Coco, F .

CANCER INVESTIGATION, 1999, 17 (08) :586-593

[2]

BECKER K, 1997, P AN M AM SOC CLIN, V16, pA283

[3] Protracted infusional 5-fluorouracil (5-FU) with bolus mitomycin in 5-FU-resistant colorectal cancer [J].

Chester, JD ;

Dent, JT ;

Wilson, G ;

Ride, E ;

Seymour, MT .

ANNALS OF ONCOLOGY, 2000, 11 (02) :235-237

[4] Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer [J].

Cunningham, D ;

Pyrhönen, S ;

James, RD ;

Punt, CJA ;

Hickish, TF ;

Heikkila, R ;

Johannesen, TB ;

Starkhammar, H ;

Topham, CA ;

Awad, L ;

Jacques, C ;

Herait, P .

LANCET, 1998, 352 (9138) :1413-1418

[5]

Henderson CA, 1998, SEMIN ONCOL, V25, P29

[6]

PIEDBOIS P, 1992, J CLIN ONCOL, V10, P896

[7] A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer [J].

Ross, P ;

Norman, A ;

Cunningham, D ;

Webb, A ;

Iveson, T ;

Padhani, A ;

Prendiville, J ;

Watson, M ;

Massey, A ;

Popescu, R ;

Oates, J .

ANNALS OF ONCOLOGY, 1997, 8 (10) :995-1001

[8]

ROSS P, 1997, P ECCO, V9, pS242

[9] Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer [J].

Rougier, P ;

Van Cutsem, E ;

Bajetta, E ;

Niederle, N ;

Possinger, K ;

Labianca, R ;

Navarro, M ;

Morant, R ;

Bleiberg, H ;

Wils, J ;

Awad, L ;

Herait, P ;

Jacques, C .

LANCET, 1998, 352 (9138) :1407-1412

[10] 5-Fluorouracil, high-dose folinic acid and mitomycin C combination chemotherapy in previously treated patients with advanced colorectal carcinoma [J].

Seitz, JF ;

Perrier, H ;

Giovannini, M ;

Capodano, G ;

Bernardini, D ;

Bardou, VJ .

JOURNAL OF CHEMOTHERAPY, 1998, 10 (03) :258-265

← 1 2 →